New study finds the composition of adipose-derived regenerative cells using InGeneron’s Transpose® RT system does not depend on the subject’s age, sex, body mass index, or ethnicity.
Category: Business & Finance
William Shatner to receive the “Inspiration and Patriotism Award”
William Shatner made history as the oldest living person to travel to space when he flew on Jeff Bezos’ Blue Origin space shuttle on Oct. 13, 2021.
Spero Health Brings Relief for Addiction and Lifesaving Care to Thousands in 2022
Spero Health released a 2022 organizational summary of the impact their outpatient addiction treatment program has had on communities struggling with the drug epidemic.
iSun Inc. completes $16.4 million transaction of development project
iSun, Inc. is a leading solar energy and clean mobility infrastructure company with 50-years of experience accelerating the adoption of innovative electrical technologies.
HeartBeam Granted European Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
HeartBeam, Inc. announced today that its patent that enables generation of a synthesized 12-lead ECG by the HeartBeam AIMIGo™ credit card-sized device was issued by the European Patent Office.
Ram 1500 Revolution Battery-electric Vehicle (BEV) Concept Unveiled at CES 2023
The Ram Revolution BEV Concept is a visionary road map showing how the industry’s leading truck brand will redefine the pickup segment once again.
Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System
Cardiovascular Systems, Inc. announced today that Innova Vascular, Inc. (Innova) has submitted a 510(k) Premarket Notification to the U.S. Food and Drug Administration (FDA) for its thrombectomy devices intended to treat peripheral vascular disease.
Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company
Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their previously announced merger of equals following the approval of each company’s stockholders at respective special meetings of stockholders held today.
Tevogen Bio Appoints Cell Therapy Expert Dr. Dolores Grosso as Global Clinical Development Lead to Accommodate Its Expanding Portfolio
Tevogen, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in virology, neurology, and oncology is reported as the highest valued tech startup of 2022.
